Pascal Carpentier | Chief Information Officer
Drugs for Neglected Diseases initiative
Pascal Carpentier holds overall responsibility for DNDi’s Information Systems management. With over 20 years of experience in both the private and public sectors, Pascal had the opportunity to develop disruptive e-Health solutions for cardiac diseases therapies at Medtronic. He also has extensive experience with NGOs; as Head of Solutions Delivery he implemented innovative finance mechanism for UNITAID. Previously, as Information System Manager he participated in the inception of GAVI Alliance and the Vaccine Fund information system. Pascal graduated with a Master’s degree in computer science specialized in Business Intelligence at Ecole Supérieure Informatique Electronique Automatique (ESIEA) in Paris and completed a Master in Business Administration at Business School Lausanne. He also holds a PhD from Erasmus University of Rotterdam 2023 on commons and open source communities. His PhD research helped improve the understanding of how these alternatives and open ways of production can help disseminate knowledge, innovations, and craft a fairer world. PMP® certified (Project Management Professional) and an active member of the PMI Switzerland Chapter (Project Management Institute), he volunteers to organize conferences promoting best practices in project management.
Appearances:
BioTechX EU Day 2 @ 13:05
Harnessing AI for Global Health Impact: Why NGOs Must Unite to Lead
AI is transforming drug discovery and clinical development faster than any organization can navigate alone. For NGOs, this isn't just a technological shift — it's a defining moment.
DNDi has spent decades proving that partnership is the most powerful engine for impact: 14 new treatments, 6 deadly diseases defeated, millions of lives saved. Now, AI is supercharging that model. From intelligent compound screening to automated clinical documentation and real-time safety surveillance, the opportunities are immense — and they are accelerating.
But here's the hard truth: no NGO can capture this potential in isolation. The data, the talent, the infrastructure required to deploy AI at scale demand a new level of collaboration. The organizations that will lead the next era of global health innovation are those bold enough to build coalitions, join consortia, and co-create shared platforms with aligned partners.
This session makes the case that AI is not just a tool — it's the catalyst for a more connected, more ambitious NGO ecosystem. The future of equitable drug development won't be built by any single organization. It will be built together.
Get involved at BioTechX Europe
Created by
Terrapinn is proud to be a member of isla.
Working together to build sustainable events